{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-308673","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2021-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.488778+00:00","generated_at":"2026-06-28T17:34:49.968771+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"HCW Biologics appoints Gary Winer and Lisa Giles to board of directors","bullets":["HCW Biologics appointed Gary Winer as Class I director and Lisa Giles as Class II director, effective Oct 25, 2021.","Both new directors appointed to audit and compensation committees; Dr. Hing Wong stepped down from audit committee.","Winer was CEO of ORGENTEC Diagnostika until Sept 2021; Giles is founder/CEO of Giles & Associates Consultancy.","Directors compensated per Non-Employee Director Compensation Policy, pro-rated; indemnification agreements to be signed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-308673","json":"https://secwatch.observer/filing/0001193125-21-308673.json","markdown":"https://secwatch.observer/filing/0001193125-21-308673.md","text":"https://secwatch.observer/filing/0001193125-21-308673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/0001193125-21-308673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/d53143d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T17:34:49.968771+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4f95debf64","claim":"Lisa Giles was appointed as Director at HCW Biologics Inc..","evidence_excerpt":"appointed Gary Winer as a Class I member of the Board and Lisa Giles as a Class II member of the Board, in each case effective October 25, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/0001193125-21-308673-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"cc0696c0bf","claim":"Gary Winer was appointed as Director at HCW Biologics Inc..","evidence_excerpt":"appointed Gary Winer as a Class I member of the Board and Lisa Giles as a Class II member of the Board, in each case effective October 25, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1828673/000119312521308673/0001193125-21-308673-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}